Cargando…
Isavuconazole: Mechanism of Action, Clinical Efficacy, and Resistance
Increasing incidence of invasive fungal infections combined with a growing population of immunocompromised hosts has created a rising need for antifungal agents. Isavuconazole, a second-generation broad-spectrum triazole with activity against yeasts, dimorphic fungi, and molds, has a favorable safet...
Autores principales: | Ellsworth, Misti, Ostrosky-Zeichner, Luis |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7712939/ https://www.ncbi.nlm.nih.gov/pubmed/33260353 http://dx.doi.org/10.3390/jof6040324 |
Ejemplares similares
-
Mind the gap: The hospital breakroom
por: Ellsworth, Misti, et al.
Publicado: (2020) -
Post-exposure prophylaxis with isavuconazole after occupational exposure to Rhizopus
por: Al-Obaidi, Mohanad, et al.
Publicado: (2018) -
2419. Increasing Misattribution of Bacteremia as CLABSIs by NHSN Definitions: A Tertiary Care Center Perspective
por: Ellsworth, Misti G, et al.
Publicado: (2023) -
1623. Implementation of Electronic Readmission Alert for Discharged Patients Reduces Risk of Secondary Measles Exposure Events
por: Boston, Kelley M, et al.
Publicado: (2019) -
Isavuconazole Treatment of Cryptococcosis and Dimorphic Mycoses
por: Thompson, George R., et al.
Publicado: (2016)